What question did this study set out to answer?

June 7, 2026Diabetes

1557-P: Diabetes Technology Use and the Acute Living Experience of Persons with Type 1 Diabetes

View Full Paper

Ask AI

Bookmark

This research assesses how the use of diabetes technology affects the acute living experience of persons with type 1 diabetes, particularly among different racial and ethnic groups.
Participants aged 14 to 40 (n=724) completed surveys on diabetes technology use, diabetic ketoacidosis, hypoglycemia, and related psychological measures.
Techuse was defined as using either continuous glucose monitors with continuous subcutaneous insulin infusion or automated insulin delivery systems.
Statistical analysis examined differences in glycemic control and acute diabetes-related events by race and technology use.
79% of Non-Hispanic White, 66% Non-Hispanic Black, and 67% Hispanic Americans reported techuse.
Techuse was associated with lower HbA1c (p=0.007) and decreased odds of DKA in Non-Hispanic White (OR=0.32), with variable effects for other groups.
Techuse linked to significantly lower odds of hypoglycemia (OR=0.44) and increased insulin treatment satisfaction (p<0.001).

No takes yet. Share an insight, caveat, or question.

Randomized trial shows diabetes technology use affects acute experiences in varied racial groups, implying disparities in treatment outcomes.

CONWAY et al. (2026) studied this question.

View Full Paper

Ask AI

Bookmark

Randomized trial shows diabetes technology use affects acute experiences in varied racial groups, implying disparities in treatment outcomes.